Ashley Canizaro, MD
Obstetrics & Gynecology · Jackson, MSNPI 1013115088
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 43.5% of the total. Reporting peaked in 2019 at $570 and has fallen 89.8% since, to $58 in 2024.
Across 127 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$796
- Astellas Pharma US Inc$268
- Pfizer$170
- Exeltis, USA Inc.$165
- Mayne Pharma Commercial LLC$66
- Applied Medical Resources Corporation$43
- plus $324 from 15 others
What the payments were for
- Food & beverage$1,80999%
- Education$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $796 |
| Astellas Pharma US Inc | 15 | $268 |
| Pfizer | 13 | $170 |
| Exeltis, USA Inc. | 9 | $165 |
| Mayne Pharma Commercial LLC | 9 | $66 |
| Applied Medical Resources Corporation | 1 | $43 |
| Novo Nordisk | 3 | $40 |
| Bayer | 3 | $36 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Shield Therapeutics Inc | 2 | $25 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Organon | 3 | $23 |
| AMAG Pharmaceuticals, Inc. | 2 | $22 |
| Amgen | 1 | $16 |
| BD | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Mimedx Group, Inc. | 1 | $13 |
| Minerva Surgical, Inc | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $12 |
| Lupin Inc. | 1 | $12 |
How this compares
$1,832 in reported general payments places this provider in the 65th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $1,119 |
| Medroxyprogesterone Acetate | 12 | $285 |
| EstaryllaNorgestimate-Ethinyl Estradiol | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Jackson
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Fred IngramJackson$8K
- Jennifer MosesJackson$8K
- Kathryn JeromeJackson$8K
- John WooleyJackson$7K
- Erica OryJackson$6K
- Amanda NicolsJackson$6K
- Leland GebhartJackson$5K
- Meredith TravelsteadJackson$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.